seqirus-us.com
Press Releases
http://www.seqirus-us.com/news-room/Seqirus-Receives-FDA-Approval-For-AFLURIA-QUADRIVALENT-Influenza-Vaccine-For-People-18-Years-Of-Age-And-Older
Include All CSL Behring Country Sites. About Seqirus United States. Images and video b-roll. Seqirus receives FDA approval for AFLURIA QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older. Cambridge, MA — 08/29/2016. Seqirus is shipping trivalent and quadrivalent formulations of AFLURIA in the 2016-2017 influenza season. Influenza Vaccine) is available in a needle-free option. Seqirus announced today that the US Food and Drug Administration (FDA) has approved AFLURIA. Influenza Vaccine) ...
seqirus-us.com
RSS Feeds
http://www.seqirus-us.com/media-room/rss-feeds.htm
Include All CSL Behring Country Sites. About Seqirus United States. Images and video b-roll. You no longer need to search across the Internet to collect Seqirus information you want to view regularly. Get news and updates about Seqirus in any RSS reader. Click on your preferred feed button(s), then select your reader from the list provided. Alternatively, you may copy and paste the URL below to your favorite RSS Feed Reader. What are RSS Feeds? Or Paste Link into Reader. RSS (Really Simple Syndication).
seqirus-us.com
About Seqirus
http://www.seqirus-us.com/s1/cs/becs/1160756085089/content/1160756084986/content.htm
Include All CSL Behring Country Sites. About Seqirus United States. About Seqirus United States. In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world. With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.
seqirus-us.com
Press Releases
http://www.seqirus-us.com/newsroom/Seqirus-To-Highlight-New-Data-In-Seasonal-Influenza-Prevention
Include All CSL Behring Country Sites. About Seqirus United States. Images and video b-roll. Seqirus to highlight new data in seasonal influenza prevention at Options IX for the Control of Influenza conference. Maidenhead, U.K. — 08/24/2016. Two poster presentations reinforce the safety of MF59. Adjuvanted seasonal trivalent influenza vaccine in adults 65 years of age and older in addition to demonstrating increased breadth of antibody responses. Presentations include data evaluating MF59. Symposium Chai...
seqirus-us.com
Products
http://www.seqirus-us.com/products.htm
Include All CSL Behring Country Sites. About Seqirus United States. In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world. AFLURIA is an inactivated (virus is not alive) influenza vaccine used for immunization against influenza disease caused by influenza virus subtypes A and B present in the vaccine. Influenza Vaccine, Adjuvanted. FLUVIRIN is a trivalent, inactivated subunit influenza virus vaccine.
seqirus-us.com
Resources
http://www.seqirus-us.com/resources.htm
Include All CSL Behring Country Sites. About Seqirus United States. BioCSL Influenza Vaccine Manufacturing Process Chart. College Student Flu Prevention PSA Video. CSL Flu Vaccine Facility Featured on ABC 7 Chicago Eyewitness News. The information presented on this site is intended for US residents only. Seqirus is a trademark of CSL Limited.
seqirus-us.com
Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children
http://www.seqirus-us.com/newsroom/Integrated-Analyses-for-Trivalent-Adjuvanted-Seasonal-Influenza-Vaccine-for-Young-Children
Include All CSL Behring Country Sites. About Seqirus United States. Images and video b-roll. Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children. Maidenhead, U.K. — 08/24/2016. Demonstrated safety profile, increased immunogenicity and efficacy compared to non-adjuvanted influenza vaccines in an analysis of more than 10,000 young children. Data from 373 young children with underlying medical conditions demonstrated that the trivalent MF59. Immunogeni...
seqirus-us.com
Site Map
http://www.seqirus-us.com/sitemap.htm
Include All CSL Behring Country Sites. About Seqirus United States. About Seqirus United States. Images and video b-roll. The information presented on this site is intended for US residents only. Seqirus is a trademark of CSL Limited.
seqirus-us.com
Seqirus now shipping its complete portfolio of seasonal influenza vaccines to US market for the 2016-2017 season
http://www.seqirus-us.com/news-room/Seqirus-shipping-complete-portfolio-of-seasonal-vaccines-to-US-market
Include All CSL Behring Country Sites. About Seqirus United States. Images and video b-roll. Seqirus now shipping its complete portfolio of seasonal influenza vaccines to US market for the 2016-2017 season. Holly Springs, NC — 08/17/2016. Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to the US market in preparation for the upcoming influenza season. Influenza Vaccine), and Fluvirin. Seqirus is now shipping to the US all influenza vaccines in its portfolio, including Fluad&...
seqirus-us.com
Authorized Distributor
http://www.seqirus-us.com/authorized-distributors.htm
Include All CSL Behring Country Sites. About Seqirus United States. Click Here for a List of Authorized Distributors. Important Safety Information for Afluria. Influenza Vaccine is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. Administration of Afluria with a needle and syringe is approved for use in persons 5 years of age and older. Administration of Afluria with the PharmaJet. If Aflur...